Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

42.23 +2.12 (+5.29%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,330,228
Open 41.85
Bid (Size) 42.25 (400)
Ask (Size) 42.40 (200)
Prev. Close 40.11
Today's Range 41.20 - 44.80
52wk Range 22.28 - 55.20
Shares Outstanding 391,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
Moderna Inc. (NASDAQ: MRNA) shares jumped 8% in early trading on February 13, 2026, after the biotechnology pioneer reported fourth-quarter 2025 financial results that exceeded Wall Street’s... 
Via MarketMinute
Topics Earnings
Top S&P500 movers in Friday's session ↗
Via Chartmill

Performance

YTD
+36.8%
+36.8%
1 Month
+6.6%
+6.6%
3 Month
+69.2%
+69.2%
6 Month
+58.2%
+58.2%
1 Year
+38.3%
+38.3%

More News

Read More
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Moderna (MRNA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Moderna Inc (NASDAQ:MRNA) Beats Q4 2025 Estimates Amid Post-Pandemic Transition ↗
Via Chartmill
News headline image
Moderna (NASDAQ:MRNA) Exceeds Q4 CY2025 Expectations
Via StockStory
Topics Artificial Intelligence
News headline image
Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates
Via ACCESS Newswire
News headline image
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI Data: Why NVDA, AAPL, TSLA, RIVN, MRNA, AMAT, IREN Are On Traders' Radar Today ↗
Via Stocktwits
Topics Bonds ETFs Economy
News headline image
Moderna: Stock to Avoid or Bad News Buy? ↗
Via The Motley Fool
News headline image
FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%
Via MarketMinute
Topics Earnings
News headline image
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
Via Finterra
Topics Initial Public Offering Intellectual Property
AI Agents and the Jobs Report Jitter: A Wall Street Balancing Act ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
What To Expect From Moderna’s (MRNA) Q4 Earnings
Via StockStory
Topics Artificial Intelligence
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
Via Finterra
Topics Artificial Intelligence Initial Public Offering Intellectual Property
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Delayed Jobs Data: Why NVDA, WBD, HOOD, MRNA, ASTS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
Why Did Moderna Stock Tumble Nearly 10% After Hours Today? ↗
Via Stocktwits
News headline image
Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Via ACCESS Newswire
News headline image
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗
Via The Motley Fool
Topics Intellectual Property
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico
Via ACCESS Newswire
News headline image
Should You Buy Moderna Before Feb. 13? ↗
Via The Motley Fool
News headline image
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
Via Finterra
Topics ETFs Economy Initial Public Offering

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 42.23
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 02/13/26 04:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 16.51B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 17B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.